Loading clinical trials...
Loading clinical trials...
Developing and Refining a Virtual Reality Intervention That Will Help to Manage Pain for People Living With Advanced Cancer
Background Pain is commonly experienced by people who are living with advanced (incurable) cancer. There is evidence to suggest virtual reality could help to relieve this pain: however, this evidence is poor quality with the intervention poorly defined. A robustly co-designed intervention, with people who have advanced cancer and experience pain, will facilitate a better evidence-base. Aim To develop and refine a virtual reality intervention that will help people living with advanced cancer to manage pain. Objectives 1. Explore and establish key components of a virtual reality intervention for people with advanced cancer in terms of effectiveness, acceptability and feasibility using in-depth interviews and focus groups with people living with advanced cancer and experiencing pain. 2. Develop and manualise a virtual reality intervention using co-design methodology. 3. User-test the intervention to refine further. Methods Multi-method design, incorporating multiple stakeholder perspectives, over three phases: Phase I. Focus groups or individual interviews with a total of 40 people, from four locations (Brighton, Cardiff, Liverpool, \& London), who have advanced cancer and experience pain. They will use the virtual reality intervention and give feedback on what resonated with them and what they would change. Phase II. Four focus groups (one at each study location) with multiple stakeholders. During this stage, the findings from phase 1 will be presented and a manual will be produced that gives guidelines on use of the virtual reality intervention. Phase III. Up to 20 people living with advanced cancer and pain will user-test the intervention over an eight-week period. During this phase, the investigators will test if/how often the virtual reality is used as part of routine practice in each site and identify any barriers of use. Anticipated Impact and Dissemination 1. A robustly co-designed intervention, ready for testing in a larger trial, to assess the clinical and cost effectiveness of virtual reality as a form of pain management. 2. Guidelines for the use of virtual reality in a clinical setting. The results will be published through academic routes (peer-reviewed publications as well as presented at national and international conferences). The investigators will also work with our group of people with lived experience and an oversight committee to establish the best other routes to disseminate the findings to the public e.g., a social media campaign, leaflets to clinical settings, blog and vlog posts.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Brighton and Sussex University Hospitals NHS Trust
Brighton, United Kingdom
Velindre University NHS Trust
Cardiff, United Kingdom
Marie Curie Hospice, Liverpool
Liverpool, United Kingdom
St Christophers Hospice, London
London, United Kingdom
Start Date
September 1, 2024
Primary Completion Date
November 30, 2025
Completion Date
November 30, 2025
Last Updated
December 6, 2024
100
ESTIMATED participants
Virtual Reality
DEVICE
Lead Sponsor
University College, London
Collaborators
NCT07213804
NCT06346132
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions